Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
LED Similarly to the other non-motor symptoms, the pooled analysis showed an insignificant improvement in the LED in the treatment groups compared to the placebo (MD = 31.53
gives a helpful overview
Patients sometimes assume the medication will be unaffordable, sometimes assume it will be cheap
Take home message In Phase 3 trials, retatrutide has produced higher weight loss than Wegovy: 28.7% at 68 weeks on the 12 mg dose, compared with 20.7% at 72 weeks on the newer Wegovy 7.2 mg dose, and 14.9% at 68 weeks on the older 2.4 mg dose
Tewari M., et al
US$ 20.40
US$ 27.33
US$ 29.73
US$ 25.43
US$ 25.19
US$ 24.94
US$ 23.62
